Clinical Trials Logo

Clinical Trial Summary

Observational, descriptive, retrospective, multicenter study to evaluate the safety of the treatment with Sebryl® and / or Sebryl Plus® in the management of seborrheic dermatitis and psoriasis of the scalp in routine medical practice.


Clinical Trial Description

The objective of this study is to evaluate the frequency and intensity of adverse events presented during treatment with Sebryl® and / or Sebryl Plus® for the management of seborrheic dermatitis and psoriasis of the scalp. The sample will be at convenience. The files of the patients who have received treatment with Sebryl® and / or Sebryl Plus® in the last 5 years (2016 to 2021) will be chosen. The researchers or the personnel designated by them will capture the information recorded by the treating physicians in the clinical file, sociodemographic, clinical and safety data that were presented after the prescription of Sebryl® and / or Sebryl Plus®. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05105139
Study type Observational
Source Laboratorios Silanes S.A. de C.V.
Contact
Status Completed
Phase
Start date November 29, 2021
Completion date February 25, 2022

See also
  Status Clinical Trial Phase
Completed NCT01703793 - Safety and Efficacy Study in Subjects With Seborrheic Dermatitis Phase 2
Completed NCT01203189 - Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo N/A
Completed NCT00991198 - The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage Phase 2
Completed NCT03567980 - A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis Phase 4
Recruiting NCT03688971 - Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis Phase 2
Recruiting NCT01139749 - Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Phase 4
Completed NCT01591070 - Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis Phase 4
Completed NCT05787860 - Ruxolitinib in Seborrheic Dermatitis Phase 2
Completed NCT00403559 - A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis Phase 2
Not yet recruiting NCT00767546 - Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients Phase 1
Terminated NCT01315951 - Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation N/A
Recruiting NCT05942248 - The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis N/A
Recruiting NCT06013371 - PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea Phase 2
Recruiting NCT05319444 - Cleansing Device for the Treatment of Scalp and Hair Conditions N/A
Completed NCT04445987 - Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis Phase 2
Completed NCT04973228 - Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM) Phase 3
Completed NCT03114111 - Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis Early Phase 1
Completed NCT02656368 - Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis N/A
Completed NCT00830908 - HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis N/A
Completed NCT02349854 - Neurobiology of the Scalp in Seborrheic Dermatitis N/A